A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cell carcinoma. The myosin 6 (MYO6) plays an important role in tumorigenesis and progression. However, its prognostic and immunological effects in ccRCC have not been comprehensively and systematically studied. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Wei, Chen, Bo, Jiang, Zhaosheng, Cai, Bo, Ma, Limin, Guan, Yangbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493793/
https://www.ncbi.nlm.nih.gov/pubmed/37701098
http://dx.doi.org/10.21037/tcr-23-227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493793/
https://www.ncbi.nlm.nih.gov/pubmed/37701098
http://dx.doi.org/10.21037/tcr-23-227

Ejemplares similares